CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-10 | Liu James Yang Sr Dir Controller PAO Int PFO | Grant or award · Option to Purchase Common Stock | +8,482 | 8,482 | ||
| 2023-08-15 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +40,000 | 40,000 | ||
| 2023-06-30 | Gutfreund John Peter Former Director | Other disposition | −3,085,047 | 0 | ||
| 2023-06-30 | Gutfreund John Peter Former Director | Other disposition · Warrants to Purchase Common Stock | −3,564,728 | 0 | ||
| 2023-06-23 | Last Andrew J. Director | Grant or award | +20,000 | 90,170 | ||
| 2023-06-23 | Last Andrew J. Director | Grant or award · Option to Purchase Common Stock | +90,000 | 90,000 | ||
| 2023-06-23 | Arno Andrew Director | Grant or award | +30,000 | 703,133 | ||
| 2023-06-23 | Arno Andrew Director | Grant or award · Option to Purchase Common Stock | +135,000 | 135,000 | ||
| 2023-06-23 | KINGSLEY ALFRED D Director | Grant or award | +20,000 | 489,111 | ||
| 2023-06-23 | KINGSLEY ALFRED D Director | Grant or award · Option to Purchase Common Stock | +90,000 | 90,000 | ||
| 2023-06-23 | SILVERMAN LOU Director | Grant or award | +25,000 | 31,270 | ||
| 2023-06-23 | SILVERMAN LOU Director | Grant or award · Option to Purchase Common Stock | +112,500 | 112,500 | ||
| 2023-06-14 | KINGSLEY ALFRED D Director | Purchase | +30,000 | $0.21 | $6K | 469,111 |
| 2023-06-09 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +350,000 | 350,000 | ||
| 2023-06-09 | Riggs Josh CEO and President | Grant or award · Option to Purchase Common Stock | +800,000 | 800,000 | ||
| 2023-04-05 | PURA VIDA INVESTMENTS, LLC 10% owner | Purchase | +663,000 | $0.30 | $200K | 8,090,202 |
| 2023-04-03 | Gutfreund John Peter Director | Grant or award | +705,000 | $0.35 | $250K | 715,000 |
| 2023-04-03 | Gutfreund John Peter Director | Grant or award | +1,000,000 | $0.35 | $354K | 1,075,000 |
| 2023-04-03 | Gutfreund John Peter Director | Returned to the company · Series A Convertible Preferred Stock | −588.24 | 0 | ||
| 2023-04-03 | Arno Andrew Director | Grant or award | +141,084 | $0.35 | $50K | 673,133 |
Page 5 of 12 · 222 trades